Page 16 - 《中国药房》2026年6期

[16] PIERI M，AGRACHEVA N，DI PRIMA A L，et al. Pri‐ thrombotic therapy for vascular diseases：an indispensable
mary anticoagulation with bivalirudin for patients with im‐ resource in vascular care[J]. Eur J Vasc Endovasc Surg，
plantable ventricular assist devices[J]. Artif Organs，2014， 2023，65（5）：621-622.
38（4）：342-346. [28] BARON S J，YEH R W，CRUZ-GONZALEZ I，et al. Ef-
[17] SYLVIA L M，ORDWAY L，PHAM D T，et al. Bivaliru‐ ficacy and safety of argatroban in patients with heparin
din for treatment of LVAD thrombosis：a case series[J]. induced thrombocytopenia undergoing endovascular inter‐
ASAIO J，2014，60（6）：744-747. vention for peripheral arterial disease[J]. Catheter Cardio‐
[18] HILLEBRAND J，SINDERMANN J，SCHMIDT C，et al. vasc Interv，2008，72（1）：116-120.
Implantation of left ventricular assist devices under extra‐ [29] TURBA U C，BOZLAR U，SIMSEK S. Catheter-directed
corporeal life support in patients with heparin-induced thrombolysis of acute lower extremity arterial thrombosis
thrombocytopenia[J]. J Artif Organs，2015，18（4）： in a patient with heparin-induced thrombocytopenia[J].
291-299. Catheter Cardiovasc Interv，2007，70（7）：1046-1050.
[19] WERT L，HANKE J S，DOGAN G，et al. Argatroban ad‐ [30] LEWIS B E，MATTHAI W H Jr，COHEN M，et al. Ar-
ministration as therapy for thrombosis in patients with gatroban anticoagulation during percutaneous coronary in‐
continuous-flow ventricular assist devices[J]. J Thorac tervention in patients with heparin-induced thrombocyto‐
Dis，2018，10（Suppl. 15）：S1720-S1727. penia[J]. Catheter Cardiovasc Interv，2002，57（2）：
[20] SAMUELS L E，KOHOUT J，CASANOVA-GHOSH E， 177-184.
et al. Argatroban as a primary or secondary postoperative [31] MAHAFFEY K W，LEWIS B E，WILDERMANN N M，
anticoagulant in patients implanted with ventricular assist et al. The anticoagulant therapy with bivalirudin to assist
devices[J]. Ann Thorac Surg，2008，85（5）：1651-1655. in the performance of percutaneous coronary intervention
[21] VANDERPLUYM C J，CANTOR R S，MACHADO D， in patients with heparin-induced thrombocytopenia
et al. Utilization and outcomes of children treated with di‐ （ATBAT）study：main results[J]. J Invasive Cardiol，2003，
rect thrombin inhibitors on paracorporeal ventricular assist 15（11）：611-616.
device support[J]. ASAIO J，2020，66（8）：939-945. [32] KASTRATI A，NEUMANN F J，MEHILLI J，et al. Bivali‐
[22] DYKE C M，ALDEA G，KOSTER A，et al. Off-pump rudin versus unfractionated heparin during percutaneous
coronary artery bypass with bivalirudin for patients with coronary intervention[J]. N Engl J Med，2008，359（7）：
heparin-induced thrombocytopenia or antiplatelet factor 688-696.
four/heparin antibodies[J]. Ann Thorac Surg，2007，84 [33] LI Y，LIANG Z Y，QIN L，et al. Bivalirudin plus a high-
（3）：836-839. dose infusion versus heparin monotherapy in patients with
[23] KOSTER A，DYKE C M，ALDEA G，et al. Bivalirudin ST-segment elevation myocardial infarction undergoing
during cardiopulmonary bypass in patients with previous primary percutaneous coronary intervention：a randomised
or acute heparin-induced thrombocytopenia and heparin trial[J]. Lancet，2022，400（10366）：1847-1857.
antibodies：results of the CHOOSE-ON trial[J]. Ann Tho‐ [34] MOSTOFA A B M，KARMOKER K K，AFRIN R，et al.
rac Surg，2007，83（2）：572-577. Safety and efficacy of bivalirudin in female acute coro‐
[24] PAPPALARDO F，ARNAEZ B，CELINSKA-SPODAR nary syndrome patients undergoing percutaneous coronary
M，et al. Bivalirudin or heparin：which anticoagulation intervention[J]. Mymensingh Med J，2025，34（2）：
strategy for critically ill cardiac surgery patients [J]. Crit 545-553.
Care，2014，18（1）：P97. [35] BROTT T G，HALPERIN J L，ABBARA S，et al. 2011
[25] NILIUS H，SINITSA E，STUDT J D，et al. Outcomes of ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/
patients with suspected heparin-induced thrombocyto- SCAI/SIR/SNIS/SVM/SVS guideline on the management
penia in a contemporary multicenter cohort[J]. Blood of patients with extracranial carotid and vertebral artery
Adv，2025，9（21）：5546-5555. disease：executive summary：a report of the American Col‐
[26] GORNIK H L，ARONOW H D，GOODNEY P P，et al. lege of Cardiology Foundation/American Heart Associa‐
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/ tion Task Force on Practice Guidelines，and the American
SVS/SIR/VESS guideline for the management of lower Stroke Association，American Association of Neurosci‐
extremity peripheral artery disease：a report of the American ence Nurses，American Association of Neurological Sur‐
College of Cardiology/American Heart Association Joint geons，American College of Radiology，American Society
Committee on clinical practice guidelines[J]. Circulation， of Neuroradiology，Congress of Neurological Surgeons，
2024，149（24）：e1313-e410. Society of Atherosclerosis Imaging and Prevention，So-
[27] GOTTSÄTER A. The European Society for Vascular Sur‐ ciety for Cardiovascular Angiography and Interventions，
gery（ESVS）2023 clinical practice guidelines on anti‐ Society of Interventional Radiology，Society of Neuro

· 698 · China Pharmacy 2026 Vol. 37 No. 6 中国药房 2026年第37卷第6期